Information about Tanai Therapeutics
My details
*
*
*

Company information

Status
Active

Enterprise number

BE1002.228.546

VAT liability
Yes
Established
13-11-2023
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Tanai Therapeutics

2024
Profit/Loss -1,804,982
Equity 6,045,018
Gross margin -224,811

Publications from Tanai Therapeutics

Date Publication
30-01-2025 Resignations - Appointments (NL)
12-07-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital - Shares (NL)
11-03-2024 Modification(s) Articles of Association (NL)
16-11-2023 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Tanai Therapeutics?
The VAT number of Tanai Therapeutics is BE 1002.228.546.
Wat is the PEPPOL ID of Tanai Therapeutics?
There is no information available about the PEPPOL ID of Tanai Therapeutics or the company is not yet registered on the PEPPOL network.
When was Tanai Therapeutics founded?
Tanai Therapeutics was founded on 13-11-2023.
What is the address of Tanai Therapeutics?
The current registered office of Tanai Therapeutics is located at Pieter van Reysschootlaan 2/104, 9051 Gent.
When was the last time Tanai Therapeutics filed their annual financial statements?
The most recent financial statements of Tanai Therapeutics were filed on 05-06-2025.
How many employees does Tanai Therapeutics have?
There are currently no employees working at Tanai Therapeutics or no workforce information is available.
What is the annual turnover of Tanai Therapeutics?
At the time of its most recent financial statements, Tanai Therapeutics did not publish any turnover figures. Tanai Therapeutics reported a gross margin of -€224,811.41.